Liu D - Search Results

1

Refractory Helicobacter pylori infection and the gastric microbiota.

Liu D, Wang J, Xie Y. Liu D, et al. Front Cell Infect Microbiol. 2022 Sep 27;12:976710. doi: 10.3389/fcimb.2022.976710. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36237432 Free PMC article.

2

Construction and characterization of recombinant attenuated Salmonella typhimurium expressing the babA2/ureI fusion gene of Helicobacter pylori.

Liu DS, Hu SJ, Zhou NJ, Xie Y, Cao J. Liu DS, et al. Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):655-60. doi: 10.1016/j.clinre.2011.06.007. Epub 2011 Jul 27. Clin Res Hepatol Gastroenterol. 2011. PMID: 21798844

3

Expression of T-cell immunoglobulin- and mucin-domain-containing molecules-1 and -3 (Tim-1 and Tim-3) in Helicobacter pylori infection.

Hu S, Xie Y, Zhou N, Jin L, Tan Y, Liu D, Gong Y, Liu L, Liu J, Liu W, Chen Y, Zhang Y, Lv N. Hu S, et al. Among authors: liu j, liu l, liu w, liu d. Helicobacter. 2011 Oct;16(5):373-81. doi: 10.1111/j.1523-5378.2011.00855.x. Helicobacter. 2011. PMID: 21923683

4

[Construction of NK4 gene lentiviral vector and its expression in bone mesenchymal stem cells].

Zhu Y, Cheng M, Lu N, Luo S, Xie Y, Liu D. Zhu Y, et al. Among authors: liu d. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011 Oct;28(5):976-81. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011. PMID: 22097267 Chinese.

5

[Efficacy of triple versus quadruple furazolidone-based eradication regimens for Helicobacter pylori infection].

Lü Z, Xie Y, Lü N, Zhou H, Liu Z, Zhu X, Chen Y, He X, Liu D, Ma J. Lü Z, et al. Among authors: liu z, liu d. Zhonghua Yi Xue Za Zhi. 2014 Mar 4;94(8):572-5. Zhonghua Yi Xue Za Zhi. 2014. PMID: 24762683 Clinical Trial. Chinese.

6

Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection.

Xie Y, Zhu Y, Zhou H, Lu ZF, Yang Z, Shu X, Guo XB, Fan HZ, Tang JH, Zeng XP, Wen JB, Li XQ, He XX, Ma JH, Liu DS, Huang CB, Xu NJ, Wang NR, Lu NH. Xie Y, et al. World J Gastroenterol. 2014 Aug 28;20(32):11415-21. doi: 10.3748/wjg.v20.i32.11415. World J Gastroenterol. 2014. PMID: 25170230 Free PMC article. Clinical Trial.

7

Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine.

Gong Y, Tao L, Wang F, Liu W, Jing L, Liu D, Hu S, Xie Y, Zhou N. Gong Y, et al. Among authors: liu w, liu d. Mol Med Rep. 2015 Sep;12(3):4123-4132. doi: 10.3892/mmr.2015.3950. Epub 2015 Jun 17. Mol Med Rep. 2015. PMID: 26095723 Free PMC article.

8

Overexpression of HMGB1 A-box reduced lipopolysaccharide-induced intestinal inflammation via HMGB1/TLR4 signaling in vitro.

Wang FC, Pei JX, Zhu J, Zhou NJ, Liu DS, Xiong HF, Liu XQ, Lin DJ, Xie Y. Wang FC, et al. World J Gastroenterol. 2015 Jul 7;21(25):7764-76. doi: 10.3748/wjg.v21.i25.7764. World J Gastroenterol. 2015. PMID: 26167076 Free PMC article.

9

Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice.

Gong Y, Tao L, Jing L, Liu D, Hu S, Liu W, Zhou N, Xie Y. Gong Y, et al. Among authors: liu w, liu d. PLoS One. 2016 Feb 22;11(2):e0149629. doi: 10.1371/journal.pone.0149629. eCollection 2016. PLoS One. 2016. PMID: 26901645 Free PMC article.

10

Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial.

Hong J, Shu X, Liu D, Zhu Y, Xie C, Xie Y, Zhang K, Wang A, Xiong H, Zeng H, Yu H, Ma J, Chen Y, Zhu X, Lu N. Hong J, et al. Among authors: liu d. J Antimicrob Chemother. 2016 Aug;71(8):2280-5. doi: 10.1093/jac/dkw118. Epub 2016 Apr 21. J Antimicrob Chemother. 2016. PMID: 27107097 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,857 results

Search Page